Exploring Canadian genetic healthcare providers’ perceptions on the increased availability and use of sponsored genetic testing and determining the downstream influences on laboratory resource allocation decisions within a public healthcare system

探索加拿大遗传医疗保健提供者对赞助基因检测的可用性和使用的增加的看法，并确定对公共医疗保健系统内实验室资源分配决策的下游影响

• 批准号: 486274
• 负责人: Hirjikaka Daena
• 金额: $ 1.27万
• 依托单位: University of Manitoba
• 依托单位国家: 加拿大
• 项目类别: Studentship Programs
• 财政年份: 2022
• 资助国家: 加拿大
• 起止时间: 2022-12-01 至 2023-12-01
• 项目状态: 已结题
• 来源: https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=486274&lang=en
• 关键词: Exploratory; Funding; Genetic Testing; Genomics; Mainstreaming; Perspectives; Policy; Providers; Resource Allocation; Sponsored

Within the Canadian healthcare system, genetic testing is publicly funded for individuals who meet provincial testing criteria and are at increased risk of having a hereditary condition. A new form of service delivery, referred to as sponsored genetic tes

在加拿大医疗保健系统内，基因检测是针对符合省级检测标准且患有遗传性疾病风险较高的个人提供公共资助的。一种新的服务提供形式，称为赞助基因测试